ZA200902005B - Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis - Google Patents

Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis

Info

Publication number
ZA200902005B
ZA200902005B ZA200902005A ZA200902005A ZA200902005B ZA 200902005 B ZA200902005 B ZA 200902005B ZA 200902005 A ZA200902005 A ZA 200902005A ZA 200902005 A ZA200902005 A ZA 200902005A ZA 200902005 B ZA200902005 B ZA 200902005B
Authority
ZA
South Africa
Prior art keywords
lipoxin
analogs
prevention
treatment
intestinal fibrosis
Prior art date
Application number
ZA200902005A
Other languages
English (en)
Inventor
John Parkinson
Stefano Fiorucci
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200902005B publication Critical patent/ZA200902005B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200902005A 2006-08-23 2009-03-20 Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis ZA200902005B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83975506P 2006-08-23 2006-08-23

Publications (1)

Publication Number Publication Date
ZA200902005B true ZA200902005B (en) 2010-05-26

Family

ID=39107156

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902005A ZA200902005B (en) 2006-08-23 2009-03-20 Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis

Country Status (18)

Country Link
US (1) US20080119439A1 (xx)
EP (1) EP2056816A2 (xx)
JP (1) JP2010501506A (xx)
KR (1) KR20090042982A (xx)
CN (1) CN101528219A (xx)
AR (1) AR062478A1 (xx)
AU (1) AU2007287770A1 (xx)
BR (1) BRPI0716576A2 (xx)
CA (1) CA2660741A1 (xx)
CL (1) CL2007002442A1 (xx)
IL (1) IL196983A0 (xx)
MX (1) MX2009001994A (xx)
PE (1) PE20081360A1 (xx)
RU (1) RU2009110244A (xx)
TW (1) TW200816991A (xx)
UY (1) UY30557A1 (xx)
WO (1) WO2008022807A2 (xx)
ZA (1) ZA200902005B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102036714A (zh) * 2008-05-22 2011-04-27 拜耳先灵医药股份有限公司 晶体2-((2s，3r，4e，6e，10e，12s)-13-(4-氟苯氧基)-2，3，12-三羟基十三碳-4，6，10-三烯-8-炔)氧基)乙酸的无水形式和水合物形式
TWI627965B (zh) 2011-11-18 2018-07-01 日東電工股份有限公司 腸道纖維化處置劑
DK3454907T3 (da) * 2016-06-03 2020-10-19 Thetis Pharmaceuticals Llc Sammensætninger og fremgangsmåder relateret til salte af specialiserede pro-løsningsmediatorer af inflammation
US20210401798A1 (en) * 2018-10-23 2021-12-30 The Brigham And Women's Hospital, Inc. Lipoxin a4 analogs and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650435A (en) * 1991-04-01 1997-07-22 Madara; James L. Modulation of inflammation related to columnar epithelia
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US6006466A (en) * 1998-08-20 1999-12-28 Washecka; John Concealed linear payout holder for fishing leader
US6831186B2 (en) * 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs

Also Published As

Publication number Publication date
BRPI0716576A2 (pt) 2014-02-18
US20080119439A1 (en) 2008-05-22
AU2007287770A1 (en) 2008-02-28
WO2008022807A3 (en) 2008-05-29
WO2008022807A2 (en) 2008-02-28
CL2007002442A1 (es) 2008-03-14
RU2009110244A (ru) 2010-09-27
TW200816991A (en) 2008-04-16
IL196983A0 (en) 2009-11-18
CN101528219A (zh) 2009-09-09
MX2009001994A (es) 2009-03-06
AR062478A1 (es) 2008-11-12
CA2660741A1 (en) 2008-02-28
UY30557A1 (es) 2008-03-31
KR20090042982A (ko) 2009-05-04
PE20081360A1 (es) 2008-11-29
EP2056816A2 (en) 2009-05-13
JP2010501506A (ja) 2010-01-21

Similar Documents

Publication Publication Date Title
HK1212598A1 (zh) 用於預防口腔疾病的組合物及方法
EP2118074A4 (en) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIAC DISEASES
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
IL194153A0 (en) Compounds for the treatment of spinal muscular atrophy and other uses
PL2086642T3 (pl) DNaza do leczenia męskiej subpłodności
EP2107909A4 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC DISORDERS
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
IL204886B (en) A pharmaceutical preparation for the treatment of disorders of the stomach and intestines independent of food consumption
ZA200707472B (en) Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
EP2119436A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
EP1996218A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
ZA201002897B (en) Prevention of allergy at weaning
EP2012807A4 (en) PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
HK1125831A1 (en) Fat accumulation inhibitor for the treatment of metabolic syndrome
IL195971A0 (en) Use of defibrotide for the inhibition of heparanase
GB0619500D0 (en) Treatment of fibrosis
EP2077838A4 (en) METHODS FOR TREATING A-RELATED DISORDERS AND COMPOSITIONS THEREFOR
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
ZA200902005B (en) Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
GB0612273D0 (en) Prevention of muscle atrophy
PL2078085T3 (pl) Allele genu prpD1 z bakterii maczugowatych
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
IL185637A (en) An instrument for the treatment and prevention of infectious diseases
HK1185345A1 (zh) 用於預防和治療心血管疾病的化合物